Fachbeirat_header.jpg

Scientific Advisory Board

To ensure a high quality of research is maintained over the long term, all Max Planck Institutes are subject to regular assessment from independent advisory boards. The board members, experts from leading international research institutions and universities, are selected by the president of the Max Planck Society on the basis of suggestions from the institutes. They are elected to the board for a maximum term of six years.

Our institute's Scientific Advisory Board is currently composed of 24 members:

  • Prof. Dr. Mike Ashfold,
    School of Chemistry, University of Bristol, Bristol, UK
  • Prof. Dr. Peer Bork,
    Structural and Computational Biology, EMBL Heidelberg, Germany
  • Prof. Dr. Cynthia J. Burrows,
    Department of Chemistry, The University of Utah, USA
  • Prof. Dr. David W. Chandler,
    Sandia National Laboratories, California, USA
  • Prof. Dr. Thomas W. Ebbesen,
    ISIS, Laboratoire des Nanostructures, Strasbourg Cedex, France
  • Prof. Dr. Witold Filipowicz,
    Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
  • Prof. Dr. Astrid Gräslund,
    Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden
  • Prof. Dr. John Griffiths,
    Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
  • Prof. Dr. Ari Helenius, (Chair of the Scientific Advisory Board), 
    Institut für Biochemie, ETH Zürich, Zürich, Switzerland
  • Prof. Dr. Johan Hofkens,
    Molecular Imaging and Photonics, KU Leuven, Leuven, Belgium
  • Prof. Dr. Laurinda Jaffe,
    School of Medicine, University of Connecticut, Farmington, USA
  • Prof. Dr. Iain Mattaj,
    Director, Fondazione Human Technopole, Milano, Italy
  • Prof. Dr. Ann McDermott,
    Department of Chemistry, Columbia University, New York, USA
  • Prof. Dr. Jane Mellor,
    Deparment of Biochemistry, University of Oxford, Oxford, UK
  • Prof. Dr. Martha Merrow, (Deputy Chair of the Scientific Advisory Board), 
    Institute of Medical Psychology, Ludwig-Maximilians-Universität München, Munich, Germany
  • Prof. Dr. Daniel M. Neumark,
    College of Chemistry, University of California, Berkeley, USA
  • Prof. Dr. Anna Marie Pyle,
    Biological & Biomedical Sciences, Yale University, New Haven, USA
  • Prof. Dr. José Rizo-Rey,
    Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, USA
  • Prof. Dr. Mark S. P. Sansom,
    Department of Biochemistry, University of Oxford, Oxford, UK
  • Prof. Dr. Randy Schekman,
    Department of Molecular and Cell Biology, University of California, Berkeley, USA
  • Prof. Dr. Thomas U. Schwartz,
    Department of Biology, Massachussetts Institute of Technology, Cambridge, USA
  • Prof. Dr. Amita Sehgal,
    Penn Medicine Neuroscience Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
  • Prof. Dr. Jeremy C. Smith,
    Oak Ridge National Laboratory, Oak Ridge, USA
  • Prof. Dr. David Tollervey,
    Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, UK
Go to Editor View